Sarah presents new research at Cancer Cell Signalling meeting

Sarah recently presented her research at a Cancer Cell Signalling meeting in Leeds. In an oral presentation to a multidisciplinary audience Sarah described how her novel approach to the discovery of small molecule inhibitors of AuroraA kinase  may lead to the development of much needed therapeutics to treat neuroblastoma.